Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Landovitz, RJ; Donnell, D; Clement, ME; Hanscom, B; Cottle, L; Coelho, L; Cabello, R; Chariyalertsak, S; Dunne, EF; Frank, I; Gallardo-Cartagena, JA; Gaur, AH; Gonzales, P; Tran, HV; Hinojosa, JC; Kallas, EG; Kelley, CF; Losso, MH; Madruga, JV; Middelkoop, K; Phanuphak, N; Santos, B; Sued, O; Huamani, JV; Overton, ET; Swaminathan, S; del Rio, C; Gulick, RM; Richardson, P; Sullivan, P; Piwowar-Manning, E; Marzinke, M; Hendrix, C; Li, MJ; Wang, Z; Marrazzo, J; Daar, E; Asmelash, A; Brown, TT; Anderson, P; Eshleman, SH; Bryan, M; Blanchette, C; Lucas, J; Psaros, C; Safren, S; Sugarman, J; Scott, H; Eron, JJ; Fields, SD; Sista, ND; Gomez-Feliciano, K; Jennings, A; Kofron, RM; Holtz, TH; Shin, K; Rooney, JF; Smith, KY; Spreen, W; Margolis, D; Rinehart, A; Adeyeye, A; Cohen, MS; McCauley, M; Grinsztejn, B

Landovitz, RJ (corresponding author), Univ Calif Los Angeles, Ctr Clin AIDS Res & Educ, 911 Broxton Ave,Ste 200, Los Angeles, CA 90024 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2021; 385 (7): 595

Abstract

Injectable Cabotegravir for Prevention of HIV Infection Antiviral medication has emerged as an important tool in the prevention of HIV infection. In t......

Full Text Link